Long-term effects of bacille calmette-guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract

Urology

Volumn 63, Issue 6, 2004, Pages 1084-1088

  Hayashida, Yasushi ^a   Nomata, Koichiro ^b   Noguchi, Mitsuru ^b   Eguchi, Jiro ^b   Koga, Sigehiko ^b   Yamashita, Shuji ^b   Hayashi, Mikio ^b   Kanatake, Hiroshi ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER IRRITATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CARCINOMA IN SITU; CAUSE OF DEATH; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HEMATURIA; HUMAN; HYDRONEPHROSIS; LOW BACK PAIN; MALE; PERFUSION; PRIORITY JOURNAL; STANDARD; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT; URINARY TRACT CARCINOMA;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDRONEPHROSIS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 2942545102     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.01.046     Document Type: Article

References (22)

1. Morales A., Eidinger D., Bruce A.W. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol. 116:1976;180-183
2. Herr H.W. Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guérin. J Urol. 134:1985;531-532
3. Keenly F.X., Kulp D.A., Bibbo M. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 157:1997;33-37
4. Studer U.E., Casanova G., Kraft R., et al. Percutaneous bacillus Calmette-Guérin perfusion of the upper urinary tract for carcinoma in situ. J Urol. 142:1989;975-977
5. Sharpe J.R., Duffy G., Chin J.L. Intrarenal bacillus Calmette- Guérin therapy for upper urinary tract carcinoma in situ. J Urol. 149:1993;457-460
6. Yokogi H., Wada Y., Mizutani M., et al. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. Br J Urol. 77:1996;676-679
7. Nishino Y., Yamamoto N., Komeda H., et al. Bacillus Calmette- Guérin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int. 85:2000;799-801
8. Nonomura N., Ono Y., Nozawa M., et al. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol. 38:2000;701-705
9. Okubo K., Ichioka K., Terada N., et al. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract long-term follow-up and natural course in cases of failure. BJU Int. 88:2001;343-347
10. Irie A., Iwamura M., Kadowaki K., et al. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology. 59:2002;53-57
11. Thalmann G.N., Markwalder R., Walter B., et al. Long-term experience with bacillus Calmette-Guérin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 168:2002;1381-1385
12. Miyake H., Eto H., Hara S., et al. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. Int J Urol. 9:2002;677-680
13. Akaza H., Kameyama S., Kakizoe T., et al. Bladder Cancer BCG Study Group. Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer and carcinoma in situ of the bladder. Nippon Hinyokika Gakkai Zasshi. 83:1992;183-189
14. Herr H.W., Whitmore W.F. Jr. Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors incidence, possible pathogenesis and management. J Urol. 138:1987;292-294
15. Skinner D.G., Richie J.P., Cooper P.H., et al. The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma. J Urol. 112:1974;68-71
16. Lamm D.L. Carcinoma in situ. Urol Clin North Am. 19:1992;499-508
17. Mori H., Miyaji B., Takahashi M., et al. Intracavitary bacillus Calmette-Guérin therapy for upper tract transitional cell carcinoma. Hinyokika Kiyo. 42:1996;257-261
18. Bellman G.C., Sweetser P., Smith A.D. Complications of intracavitary bacillus Calmette-Guérin after percutaneous resection of upper tract transitional cell carcinoma. J Urol. 151:1994;13-15
19. Braslis K.G., Soloway M.S. Management of ureteral and renal pelvic recurrence after cystectomy. Urol Clin North Am. 21:1994;653-659
20. Tomera K.M., Leary F.J., Zincke H. Pyeloscopy in urothelial tumors. J Urol. 127:1982;1088-1089
21. Okubo K., Ishitoya S., Maeda H., et al. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract. Nippon Hinyokika Gakkai Zasshi. 88:1997;386-390
22. Catalona W.J., Hudson M.A., Gillen D.P., et al. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. J Urol. 137:1987;220-224